Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease (original) (raw)

Decreased Amyloid 1-42 and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease

2003

Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia

Brain : a journal of neurology, 2015

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

Koichi Ishiguro

Annals of Neurology, 1998

View PDFchevron_right

Cerebrospinal fluid tau and β-amyloid in Alzheimer patients, disease controls and an age-matched random sample

Ekkehard Haen

Neurobiology of Aging, 2006

View PDFchevron_right

Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand

vorapun senanarong

Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2011

View PDFchevron_right

Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study

Eugeen Vanmechelen

Journal of Neurology, Neurosurgery & Psychiatry, 1998

View PDFchevron_right

Tau and Aβ42 in Cerebrospinal Fluid from Healthy Adults 21–93 Years of Age: Establishment of Reference Values

Eugeen Vanmechelen

Clinical Chemistry, 2001

View PDFchevron_right

P CSF Levels of Tau Protein and Beta Amyloid in Diagnosis of Alzheimer ́ S Disease

Jan Kremlacek

2004

View PDFchevron_right

Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles

Constance Delaby

Journal of Neural Transmission, 2022

View PDFchevron_right

Interactions between Amyloid-β and Tau in Cerebrospinal Fluid of People with Mild Cognitive Impairment and Alzheimer's Disease

Daniela Řípová

Journal of Alzheimer's disease: JAD

View PDFchevron_right

Comparison of two commercial enzyme-linked immunosorbent assays for cerebrospinal fluid measurement of amyloid β1–42 and total tau

Fran Borovecki, Goran Simic

Translational Neuroscience, 2013

View PDFchevron_right

Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: Beta-amyloid(1-42), tau, phospho-tau-181 and total protein

Josef Marksteiner

Drugs of Today, 2007

View PDFchevron_right

Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity

Elisabet Londos

International Journal of Geriatric Psychiatry, 2010

View PDFchevron_right

667 Detection of tau proteins in cerebrospinal fluids from Alzheimer's patients

Didier Lefranc

Neurobiology of Aging, 1996

View PDFchevron_right

Tau and Ab42 in Cerebrospinal Fluid from Healthy Adults 21-93 Years of Age: Establishment of Reference Values

Niels Andreasen

2000

View PDFchevron_right

Comparison of Analytical Platforms for Cerebrospinal Fluid Measures of β-Amyloid 1-42, Total tau, and P-tau₁₈₁ for Identifying Alzheimer Disease Amyloid Plaque Pathology

Hugo Vanderstichele

Archives of Neurology, 2011

View PDFchevron_right

Simultaneous Measurement of -Amyloid(1-42), Total Tau, and Phosphorylated Tau (Thr181) in Cerebrospinal Fluid by the xMAP Technology

Hugo Vanderstichele, Annika Ohrfelt

Clinical Chemistry, 2005

View PDFchevron_right

Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals

Jérôme Vialaret

View PDFchevron_right

Neurochemical diagnosis of Alzheimer's dementia by CSF Aβ42, Aβ42/Aβ40 ratio and total tau

Andreas Henkel

Neurobiology of Aging, 2004

View PDFchevron_right

Cerebrospinal Fluid Tau and β-Amyloid

D. Ewbank

Archives of Neurology, 2003

View PDFchevron_right

Cerebrospinal Fluid Amyloid ss42/Phosphorylated Tau Ratio Discriminates Between Alzheimer's Disease and Vascular Dementia

H. Kremer

The Journals of Gerontology, 2006

View PDFchevron_right

CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

Anders Clarberg

Journal of Neural Transmission, 2000

View PDFchevron_right

CSF levels of tau, β-amyloid 1-42 and GAP-43 in frontotemporal dementia, other types of dementia and normal aging

Eugeen Vanmechelen

Journal of Neural Transmission, 2000

View PDFchevron_right

Cerebrospinal fluid τ and β-amyloid(1-42) in dementia disorders

Hugo Vanderstichele

2001

View PDFchevron_right

Tau Protein in Cerebrospinal Fluid

Eugeen Vanmechelen

Alzheimer Disease & Associated Disorders, 1998

View PDFchevron_right

Decreased β-Amyloid1-42and Increased Tau Levels in Cerebrospinal Fluid of Patients With Alzheimer Disease (original) (raw)

Related papers